Hearing the Light: A Behavioral and Neurophysiological Comparison of Two Optogenetic Strategies for Direct Excitation of Central Auditory Pathways by Chen, Jenny X.
Hearing the Light: A Behavioral and
Neurophysiological Comparison of
Two Optogenetic Strategies for Direct
Excitation of Central Auditory Pathways
The Harvard community has made this
article openly available.  Please share  how
this access benefits you. Your story matters
Citation Chen, Jenny X. 2016. Hearing the Light: A Behavioral and
Neurophysiological Comparison of Two Optogenetic Strategies
for Direct Excitation of Central Auditory Pathways. Doctoral
dissertation, Harvard Medical School.
Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:27007736
Terms of Use This article was downloaded from Harvard University’s DASH
repository, and is made available under the terms and conditions






For deaf individuals with absent/damaged cochleae or auditory nerves, the 
auditory brainstem implant (ABI) is the only option to restore hearing. However, most 
ABI users have only sound awareness without meaningful speech comprehension. These 
electrical implants are limited by crosstalk between neighboring electrodes that 
indiscriminately activates large groups of neurons. In contrast, optogenetics provides a 
means to manipulate neural circuits with temporal and spatial precision by using light to 
activate genetically modified neurons expressing light-gated ion channels called 
channelrhodopsins. However, central auditory neurons fire at speeds that exceed the 
limits of most available channelrhodopsins. In this study, we explored the feasibility of 
an optogenetic auditory prosthesis by infecting neurons of the murine inferior colliculus 
(ICc) with viruses expressing standard channelrhodopsin-2 (ChR2) and Chronos, a newly 
discovered opsin with ultra-fast channel kinetics.   
Through extracellular in vivo recordings in the ICc, we found that while ChR2-
driven neurons can synchronize stimulation rates up to nearly 80 Hz, neurons infected 
with Chronos entrained pulses as fast as 200 Hz, approximating the synchronization limit 
for natural acoustic input in the midbrain. Optical stimulation of Chronos at rates as high 
as 300 Hz evoked minimally-adapting responses, although spikes were no longer fully 
synchronized.  Chronos mediated responses support a superior code for the detection and 
discrimination of high pulse rates as compared with ChR2. 
It was hypothesized that this improved temporal fidelity might translate into better 
behavioral detection of optogenetic stimulation. After unilateral ICc injections of saline 
or viral constructs, mice were trained to perform an auditory avoidance task. An optic 
fiber assembly was implanted into the injected ICc and the detection task was repeated 
with photostimulation in the place of acoustic input. Chronos and ChR2 expressing mice 
exhibited similar detection slopes, while saline injected animals performed at chance. 
These findings suggest that while Chronos can transform a range of stimulation 
patterns with higher accuracy compared with ChR2, this does not translate into a 
perceptual advantage. This project has implications for both the future design of auditory 
prostheses and our understanding of signal processing in central auditory pathways. 
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Glossary of abbreviations 
AAV – adenoassociated virus 
ABI – auditory brainstem implant 
AMI – auditory midbrain implant 
ChR2 – channelrhodopsin 2 
ICc – inferior colliculus 
NBN – narrow band noise 
NF2 – neurofibromatosis type 2 






The history of auditory implants 
The World Health Organization estimates that 360 million people, representing 
nearly 5% of the world’s population, suffer from disabling hearing loss with functional, 
social, and economic consequences (1). For the treatment of severe hearing loss, the 
development of auditory implants such as cochlear and brainstem implants has enabled 
patients worldwide to regain partial restoration of hearing (2).  
The history of the first electrically stimulating auditory implant dates back to the 
18th century, shortly after Alessandro Volta invented the first electrolytic cell. During one 
experiment, Volta connected a battery to two metal rods and discovered that when he 
inserted the rods into his ear canals he felt a jolt and heard a crackling noise (3). In 1957, 
Djourno and Eyries electrically stimulated the auditory nerve of a patient during surgery, 
causing the previously bilaterally deaf patient to report sounds (4). Subsequent 
experiments by House, Doyle and Simmons in the 1960’s spurred the development of the 
first auditory implant in 1972 wherein a single electrode was placed into the cochlea of a 
patient with damaged cochlear hair cells. The first implant was simple but provided users 
with significant speech reading enhancements (5). Over time, implants came to have as 
many as 22 electrodes. In the cochlea, hair cells and their respective nerve fibers in the 
cochlea are maximally stimulated by frequencies of decreasing magnitude as sound 
travels from the base to the apex. Thus, multiple electrodes placed along this tonotopic 
map in the cochlea can stimulate spiral ganglion cells tuned to different sound 
frequencies.  
Just years after the invention of the cochlear implant, in 1979, patients with 
absent/damaged cochleae or auditory nerves inspired the first auditory brainstem implant 
(ABI).  These patients include those with auditory nerve aplasia from narrow internal 
auditory canals, traumatic injury to the auditory nerve, or congenital malformations of the 
cochlea. A subset of patients has a rare genetic syndrome called neurofibromatosis type 2 
(NF2) that is found in 1 in 33,000 newborns (6). These individuals develop bilateral skull 
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base tumors called vestibular schwannomas; the surgical resection of these tumors results 
in post-lingual severe to profound hearing loss in both ears. Because the auditory nerve is 
damaged or severed, cochlear implantation is not a therapeutic option.  
The first ABI was pioneered at the House Ear Institute to treat a patient with NF2 
(7). It was a simple contraption with two ball electrodes placed on the surface of the 
patient’s cochlear nucleus. Penetrating electrodes were later developed and organized in 
arrays of 8-16 channels to increase the complexity of stimulation and better harness the 
tonotopic organization of the cochlear nucleus (8). 
Modern auditory prostheses: cochlear implants, ABIs, AMIs 
The modern auditory implant has 5 functional components (Figure 1a). 
Externally, there is a microphone, a speech processor and a transmitter. The microphone 
curves around the ear and serves to gather sound information and deliver it to the speech 
processor. The speech processor may be housed separately from the ear piece or, in 
newer models, can be incorporated into the hardware that sits behind the ear. The speech 
processor is a computer that separates sounds into different frequency spectrums and 
organizes the information into an electrical code. The processor transmits this spectral 
and temporal information about incoming sound to a transmitter that delivers the signal to 
the internal components of the implant: the receiver and the stimulating electrode array.  
The transmitter sends signals to the receiver that is implanted just underneath the skin 
above the ear. In cochlear implants, the receiver passes the coded signals to the electrode 
array that wraps into the cochlea and the resultant electrical stimulation from specific 
electrodes causes groups of auditory nerve fibers to fire, delivering auditory sensations 
(Figure 1b). In auditory brainstem implants, the final electrode array stimulates not the 
cochlea but higher order auditory neurons of the brainstem (Figure 1c).  
 Worldwide, approximately 324,200 people have undergone cochlear implantation 
(9) and more than 1,000 patients have benefited from ABIs (10). The results of cochlear 
implantation can be life changing: adults report substantial improvements in speech 
understanding as soon as 3 months after surgery (11,12). Children with cochlear implants 
benefit from dramatic gains in speech and language development. In one study following 
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pediatric patients 10-14 years after initial implantation, 77% of patients had speech 
intelligible to an average listener and all patients were in school or employed and actively 
engaged in their communities (13).  
The outcomes of ABI users are more varied: follow-up studies indicate that this 
device has a range of audiological responses in implanted patients, from modest gains in 
sound appreciation to the acquisition of excellent speech recognition in a minority of 
people, enabling even telephone conversations (14). Most studies conclude that ABIs 
allow 85% (15) to 96.2% (16) of patients to hear environmental sounds. ABIs have also 
been shown to enhance lip reading (16–18). However, estimates suggest that as many as 
18% (19) of patients do not perceive benefits from their ABIs. Moreover, patients with 
NF2 have been shown to have particularly poor results, perhaps stemming from tumor- or 
surgery-related damage to the cochlear nucleus or surrounding brain tissues (20–22).  
To improve NF2 patient outcomes and bypass any surgical or tumor-mediated 
damage to the cochlear nucleus, a different type of brainstem implant called the auditory 
midbrain implant (AMI) was developed to stimulate hearing at an even more proximal 
structure: the inferior colliculus (ICc). To date, three patients have been implanted in 
initial clinical trials, demonstrating improved hearing responses in all three patients (22). 
The patient with the most optimally positioned AMI gained sound perception and 
significant improvements in consonant and number recognition, as well as enhancements 
in lip reading accuracy (22). 
The limitations of an electrical implant 
Despite these ongoing advances in the hardware and software components of 
cochlear implants and ABIs, specific challenges remain for patients in search of hearing 
restoration. One key limitation of all auditory prostheses (cochlear implants, ABIs, 
AMIs) remains: the use of electricity restricts the density of electrode stimulation. When 
multiple electrodes are simultaneously active, electrical field interactions can disrupt 
individual waveforms and this spread of current decreases hearing sensitivity and 
accuracy (23–26). For example, while modern cochlear implants employ 1-2 dozen  
electrodes, studies suggest that no more than 4-8 distinct sites should be active at any one 
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time because of the substantial overlaps from nearby electrodes as they sit in the 
conductive fluid of the perilymph (Fishman, Shannon, & Slattery, 1997; Friesen, 
Shannon, Baskent, & Wang, 2001; Garnham, Os’Driscoll, Ramsden And, & Saeed, 
2002). This makes poor use of the nearly 30,000 tonopically organized spiral ganglion 
neurons that are fine tuned to specific frequencies. As such, current cochlear implant 
technology enables open speech comprehension, but hearing in noisy environments and 
music appreciation is limited (22,23).  
Similarly, studies of multi-channel ABIs suggest that increasing the number of 
electrodes beyond 5 does not significantly improve perceptual outcomes (31). In auditory 
brainstem implants, these spreading fields of electrical stimulation may be even more 
important as central auditory systems consist of complex networks of excitatory and 
inhibitory interneurons as well as supporting glial cells that may all be affected by 
unfocused electrical stimulation. Moreover, some ABI users experience side effects such 
as pain and dizziness as non-auditory neurons are activated  (32). 
New technology: optogenetics 
Due to the aforementioned limitations of electricity-based implants, other 
strategies for neuronal stimulation are being explored for use in auditory prostheses, 
including multipolar stimulation (33), intraneural stimulation (34) and optical 
stimulation. Light energy has been proposed as an exciting alternative to electrical 
stimulation in auditory prostheses specifically because its resolution is not so limited by 
spreading field interactions (35,36) and can thereby better harness the fine grained 
spatial-temporal resolution of auditory centers. 
Two optical strategies are under investigation for the use in auditory implants: 
infrared stimulation and optogenetic stimulation. In the former, infrared light has been 
shown to depolarize unmodified neurons with less spread of neural activation in the 
cochlea. However, the long term repercussions of this direct stimulation on sensitive 
neural tissue is not understood. Infrared light generates thermal gradients to depolarize 
neurons, which results in the accumulation of heat energy that may be harmful to tissues 
(37,38). Moreover, the energy required for infrared stimulation exceeds what is practical 
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for use in portable prostheses (39). Recently, the use of infrared light has even been 
challenged by the finding that infrared stimulation does not trigger auditory activity in 
completely deafened cochleae, suggesting that neuronal responses could be an artifact of 
optoacoustic stimulation by the high energy laser pulses (40). 
 Thus, research has turned optogenetic technology, an alternative technique that 
employs genetically modified neurons that express light-gated ion-channels to manipulate 
specific neural circuits. Through using these light-sensitive opsins, lower levels of light 
energy are required for optogenetic depolarization of neurons as compared with infrared 
stimulation (41).  Ten years ago, the first opsin “Channelrhodopsin2” (ChR2) was 
isolated from the green algae C. reinhardtii and virally expressed on the surface of 
neurons (42,43). It was discovered that, in the presence of blue light, channelrhodopsins 
depolarize neurons by conducting cations into cells. It has been shown since  that ChR2-
expressing neurons can be activated by focused beams of visible light with spatial 
selectivity on the scale of microns in the murine brain (44).  
Only a few studies to date have applied optogenetics to the auditory nervous 
system. A pilot investigation of ChR2-expressing transgenic mice has shown that optical 
stimulation of spiral ganglion cells evokes auditory brainstem responses and local field 
potentials upstream in the inferior colliculus (ICc) (41). Others have shown that 
channelrhodopsins introduced with adenoassociated viruses (AAVs) could be used to 
drive neuronal activity throughout the auditory nervous system, from the cochlea to the 
auditory cortex (41,45).  AAVs do not integrate into the genome, but enable lasting 
expression of opsins (up to at least 18 months in murine neurons) without causing cellular 
toxicity (46). 
A range of ethical and medical hurdles stand between current studies that 
manipulate virally delivered opsins in the basic science lab and the future use of 
optogenetic technologies in human patients. For specific application in the auditory 
nervous system, one fundamental problem remains: most existing channelrhodopsins 
have inherently slow channel kinetics, which reduces their ability to deliver long lasting, 
high-frequency neural stimulation above 40-50 Hz (42,47). In contrast, central auditory 
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neurons are known to fire at several hundred hertz with exceptional temporal precision to 
encode the rapidly changing characteristics of human speech (48,49). The ability to 
faithfully encode neural representations of sound requires an opsin that could reproduce 
this level of precise, non-adapting neuronal activity. 
Recently, a novel channelrhodopsin named “Chronos” was isolated from the algal 
species Stigeoclonium helveticum. Patch clamp recordings from cultured neurons and 
brain slices initially demonstrate that Chronos has the fastest channel kinetics of any 
channelrhodopsin described to date combined with high light sensitivity (50). The speed 
of this new opsin has been attributed to its ultra-fast deactivation time of approximately 
3ms, compared with ChR2 at 20 ms. Recent in vivo studies have found that Chronos is 
able to drive neurons of the murine cochlear nucleus at high stimulation rates (51). The 
discovery of Chronos begs application in the field of auditory prostheses as a way to use 
optogenetics to bypass the longstanding limitations of electrical devices.  
In this thesis project, I compared Chronos and standard ChR2 in the first murine 
model of an optogenetic auditory brainstem prosthesis. I first determined whether 
Chronos has superior temporal fidelity compared with ChR2 in vivo in the auditory 
midbrain. I then explored whether optogenetic stimulation of the murine ICc with 
Chronos or ChR2 translates into differences in perception in a murine behavioral 
detection task. These experiments demonstrate how Chronos opens new doors to a future 
optogenetic auditory implant, while highlighting the technical challenges in replicating 
the complex neuronal circuits that encode sound. Moreover, the development of the first 
mouse model of a midbrain optogenetic implant represents a foundational step for the 
future design of optically stimulating auditory implants. The data presented hereon have 






Reproduced with minor alterations from Guo et al. (52) 
Ethics 
All procedures were approved by the Massachusetts Eye and Ear Infirmary 
Animal Care and Use Committee and followed guidelines established by the National 
Institute of Health for the care of laboratory animals. 20 CBA/CaJ mice were used in this 
study (10 for in vivo ICc recordings; 10 for behavioral assessments and in vivo auditory 
cortex recordings). 
Virus injection 
Live adeno-associated viruses (AAV) encoding AAV-CAG-ChR2-mCherry or 
AAV-Synapsin-Chronos-GFP were obtained courtesy of collaborators from the Edward 
Boyden lab at MIT. Adult male CBA/CaJ mice aged 8–10 weeks were sedated with 
isoflurane (5% in oxygen), then anesthetized with ketamine (100 mg/kg) and xylazine 
(10 mg/kg). A surgical plane of anesthesia was maintained with supplements of ketamine 
(50 mg/kg) as needed. Throughout the procedure, the animal’s body temperature was kept 
near 36.5 °C with a homeothermic blanket system. After numbing the scalp with 0.5% 
lidocaine, an incision was made along the midline, exposing the skull around the 
lambdoid suture. A small craniotomy (0.2 × 0.2 mm, with the medial-rostral corner 
positioned at 0.4 mm lateral and 0.1 mm caudal to lambda) was made with a scalpel to 
expose the right inferior colliculus. The dura mater was left intact. Electrophysiological 
recordings were made to identify the location of the central nucleus (ICc) before virus 
injection (See acute electrophysiology in the IC). Glass capillary pipettes were pulled and 
back filled with mineral oil before loading with virus. A motorized stereotaxic injector 
(Stoelting Co.) was used to inject 0.3–0.5 μl of virus expressing Chronos or ChR2 into 
the right ICc of the mouse, approximately 700 μm below the brain surface at a rate of 
0.05 μl/min. The pipette was left in place for an additional 10 minutes before withdrawal. 
The craniotomy was covered with high viscosity silicon oil, and the skin was sutured 
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closed. Mice were allowed to recover for 48 hours before behavioral training with NBN 
and at least 3 weeks before detection was measured with laser stimulation. 
Acute electrophysiology in the ICc 
The surgical procedure was similar as described in the previous section. Mice 
were anesthetized and craniotomies were performed over the right ICc. Single-shank 
multi-channel silicon optrodes (NeuroNexus Technologies) were used to deliver laser 
pulses and record neural activity (sampled at 24 kHz, digitized at 32 bit, and then band-
pass filtered between 300 to 5000 Hz with second-order Butterworth filters). Multiunit 
spike events on each channel were time stamped at threshold crossing (4.5 s.d. above a 
10 s running average of the baseline activity, SpikePac, Tucker-Davis Technologies). All 
recordings were performed in a double-walled sound-attenuating chamber. The ICc was 
identified according to the dorsal-ventral low-high tonotopic organization as defined by a 
pseudorandom series of pure tone pips (4–64 kHz in 0.1 octave steps, 0–60 dB SPL in 
5 dB steps, 50 ms duration with 5 ms cosine ramps at the onsets and offsets, 500 ms inter-
trial intervals) presented to the contralateral ear with a custom-built, calibrated in-ear 
acoustic system. 
Laser pulses (473 nm, 1 ms pulse width, 1 s total duration, LaserGlow Co.) were 
presented at various rates (20 to 300 Hz, 20 Hz steps) to the IC via the optic fiber on the 
optrode, which was positioned 0.2 mm above the topmost recording site. To avoid 
potential contamination through photoelectric artifacts, threshold crossings during the 
laser pulse were disregarded. Laser powers were selected to generate suprathreshold 
responses in the infected tissue on a case-by-case basis, and were generally in the range 
of 5 to 7 mW. For comparison, narrowband noise bursts (filtered from broadband noise 
stimuli using fourth-order Butterworth filters, 20 kHz center frequency and 0.25 octave 
bandwidth, 1 ms duration, 60 dB SPL) were presented at the same rates via the 
contralateral in-ear acoustic system. Laser and acoustic stimulation were presented in a 




Optic fiber implantation 
Following 2–6 weeks of behavioral testing with acoustic stimuli, mice were 
anesthetized with ketamine and xylazine, as described previously. An implantable 4 mm 
optic fiber assembly (NeuroNexus NNC fiber) was advanced 0.35 mm into the ICc along 
the previous injection site. The implant was then cemented to the skull (C&B Metabond). 
Mice were allowed to recover for at least 48 hours prior to the continuation of behavioral 
testing. 
Behavioral testing 
Behavioral training was carried out in an acoustically transparent enclosure 
(8 × 6 × 12 inch, L × W × H) bisected into two virtual zones resting atop electrified 
flooring (8 pole scrambled shocker, Coulbourn Instruments). Mouse position was tracked 
with a commercial PC webcam. Auditory stimuli were delivered through a free-field 
speaker positioned above the apparatus to provide a relatively homogenous sound field 
(Tucker-Davis Technologies). Mice were given at least five minutes to acclimate to the 
apparatus before each day of testing. Naïve mice were initially shaped to cross between 
zones of the chamber to terminate a foot shock (60 Hz, 0.5–1 mA, according to the 
minimally effective intensity for each mouse). With conditioned crossing behavior 
established, mice were then trained to associate sound (white noise, 5 s duration, 5 ms 
cosine ramps, 70 dB SPL) with foot shock initiated 5 s later. Crossing within the 5 s 
window was scored as a hit and the foot shock was avoided. Foot shock was initiated if 
the mouse failed to cross within the 5 s period (a miss) and was terminated upon crossing 
sides or 10 s, whichever occurred first. Once the hit rate stabilized at ≥ 70%, white noise 
was replaced with the narrow-band noise bursts and training continued until crossing 
behavior stabilized again. Psychometric functions were acquired by documenting the hit 
probability at different sound levels (−10 to 70 dB SPL in 10 dB steps) and pulse rates 
(60–300 Hz in 60 Hz steps). Stimuli were presented in a pseudo random fashion and 
repeated at least 15 times each. Inter-trial intervals were randomly drawn from a uniform 
distribution between 30 to 40 seconds. False positives were calculated as animal’s 
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crossing probability during a 5 s window halfway through the inter-trial period. 
Typically, each animal performed 60 to 100 trials per day, 5 to 6 days per week. 
For behavioral experiments involving detection of laser pulse trains, the implanted 
midbrain assembly was tethered to the laser with a patch cable. Mice were given 
10 minutes to acclimate to tethering before conditioned crossing behavior was initially 
reestablished with broadband noise stimulus. Once the hit probability was comparable to 
that documented without tethering, the acoustic stimulus was replace by laser stimuli 
(1 ms laser pulses, 60 to 300 Hz in 60 Hz steps) without any additional behavioral 
shaping. Due to the variability of sensitivity introduced by injection volume and 
expression level of the opsins, the range of laser intensity tested was adjusted on a case-
by-case basis for each animal to generate a range of subthreshold to suprathreshold 
behavioral responses. In all other respects, stimulus design and task organization were 
identical to the acoustic version of the task. 
Histology 
Animals were deeply anesthetized with ketamine and prepared for transcardial 
perfusion with 4% formalin solution. The brains were extracted and post-fixed in 4% 
formalin at room temperature for an additional 12 hours before transfer to 30% sucrose 
solution. Brain sections (60 μm thick) were counterstained with DAPI (Life 
Technologies). The location and size of the infection zone was inferred through 
visualization of the fluorescent label with a conventional fluorescence microscope 
(Zeiss). 
Data analysis 
Firing rate adaptation was quantified by calculating the ratio of the spike count to 
the first pulse divided by the average spike count to all remaining pulses within the 1 s 
period. To quantify the temporal fidelity of sound or laser evoked activities, a template-
based classifier model was used. For any given recording site, half the trials of responses 
to all pulse rates were used to build peristimulus time histogram (PSTH) based templates; 
the other half of the trials were used as test cases. Test trials were compared with the 
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templates by calculating their cross correlation coefficients. The decoded pulse rate for a 
test trial was the pulse rate behind the most similar template (highest cross correlation 
coefficient). The decoding accuracy for all rates was calculated and averaged across 
recording sites. Pulse train detectability was quantified by dividing the PSTH into 100 ms 
bins and calculating the firing rates for each bin within the spontaneous and evoked 
periods on a single trial basis. For any given bin, its detectability was quantified as the 
rectified z-score of its spike count with respect to the baseline distribution. The difference 
between mean z-scores from the spontaneous and evoked periods for each trial provided 
the basis for calculating d’.  
Statistical analyses 
All statistical analyses were performed in Matlab (Mathworks). Repeated 
measures ANOVAs were used to compare neural or behavioral measurements over 
dependent variables such as pulse rate or sound intensity in the same group of animals. 
When comparing measurements across different groups of animals, mixed-designed 
ANOVAs were used, and the main effects were reported. Multiple comparisons were 





Chronos expressing neurons can entrain a wide range of laser stimulation rates 
To investigate the in vivo differences between ChR2 and the novel opsin Chronos, 
viruses expressing each opsin were introduced into murine ICc. Chronos and ChR2 
expression in the auditory midbrain was confirmed by histological assessment of GFP 
and mCherry reporters respectively (Figure 2a). The ability of opsins to entrain light 
pulses of varying frequencies (200-300 Hz) with high fidelity was compared with the 
response of the ICc neurons to similar frequencies of NBN. We discovered that while 
ChR2 expressing neuronal multiunits were able to synchronize firing to laser stimulation 
up to pulse rates less than 80 Hz, Chronos expressing neurons demonstrated high fidelity 
entrainment to rates as high as 200 Hz. For even higher pulse rates, Chronos expressing 
neurons generated more sustained, albeit not fully synchronized, activity as compared 
with ChR2 (Figure 2b-c).   
With repeated stimulation, neurons exhibit spike frequency adaptation whereby 
neurons become less excitable following the initial response. This is theorized to be 
caused by a variety of mechanisms including the slow recovery of sodium channels after 
the initial depolarization, as well as activity dependent activations of alternate ion 
channels that hyperpolarize the cell after the initial depolarization. As auditory neurons 
are known to operate with extreme temporal precision, we examined how spike 
frequency adaptation rates change in neurons activated by light-activating opsins as 
compared with NBN. The spike rate ratio was calculated between the first and the 
following stimulus pulses after each train of optogenetic or acoustic stimulation (Figure 
2d). For all modes of activation (laser activation of opsins and NBN activation of 
intrinsic auditory pathways), rates of adaptation increased for increasing pulse rates 
(repeated-measures ANOVA, n=388, df=14, p=2.9x10^-6).  ChR2 showed  more 
significant adaptation than NBN (mixed-design ANOVA, n=117/160, df=1, p=2.9x10^-
6) but at high pulse rates, Chronos expressing neurons demonstrated significantly less 
adaptation than even neurons activated by NBN (mixed-design ANOVA, n=111/160, 
df=1, p=9.0x10^-13).  
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In further analysis to characterize the fidelity of signal transmission, a subset of in 
vivo recordings were used to create PSTH-based classifier models for Chronos, ChR2 and 
NBN-induced neuronal activity (see Data analysis in Methods). The more distinct the 
patterns of spiking at each pulse rate, the more accurately the classifier model is able to 
predict the rates of new sets of laser stimuli from recordings of responding neural multi-
units. Confusion matrices showing correct and incorrect classifications for laser 
stimulation of each opsin and for NBN are shown in Figure 3. Chronos-based classifier 
models were significantly more likely to correctly classify new stimulus rates compared 
with those constructed using ChR2 or NBN (mixed-design ANOVAs; Chronos vs. ChR2: 
n=117/160, df=1, p=9.0x10^-13; Chronos vs. NBN: n=111/160, df=1, p=6.0x10^-6).  
ChR2 and NBN models were not statistically significantly different (mixed design 
ANOVA; n=117/160, df=1, p=0.50).  
These PSTH classifier models showed how the opsins allow midbrain neurons to 
encode different pulse rates, but do not characterize the salience of the neural 
information. To examine this, we counted the number of spikes in each 0.1s bin in the 1s 
interval before and after an episode of laser/acoustic stimulation (Figure 4a), and found 
the distributions of neural spikes during spontaneous and evoked times (4b). Spike counts 
from spontaneous and evoked periods were then converted into Z scores, which were 
taken as their absolute values because both positive and negative deviations may 
represent neural information (figure 4c). We then calculated the sensitivity index d’ as the 
separation between the spike distributions for “hits” (firing during evoked periods) 
compared with “false positives” (spontaneous neural activity) (Figure 4d). We found that 
NBN and Chronos had significantly higher d’ values compared with ChR2, which 
became increasingly obvious at higher stimulation rates (mixed-design ANOVAs; ChR2 
vs. NBN: n = 117/160, df = 1, p = 1.5 × 10^−10; ChR2 vs. Chronos: n = 111/160, df =1, 
p=1.5 × 10^−12).  
Thus, Chronos allows neurons to entrain high pulse rates with higher fidelity and 
greater discriminability than ChR2. These rates are compatible with the speeds 
commanded by neurons of the central auditory system. These findings inspired further 
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experiments to determine whether Chronos’ advantage over older generation of opsins 
(ChR2) would support enhanced behavioral detection of photostimulation in the ICc.  
Behavioral detection of ICc stimulation is similar for Chronos and ChR2 expressing 
animals at different pulse rates 
We created the first murine behavioral model of an optogenetic auditory implant 
to investigate whether optogenetic tools can be used to simulate auditory percepts and 
determine if Chronos is superior to ChR2 in conveying an actionable auditory percept. 
Mice were injected with viral constructs expressing Chronos or ChR2 in the ICc (n=3 
respectively). Similarly, 2 control mice were injected with saline. All animals were 
trained in an auditory avoidance task to report detection of acoustic or optogenetic 
stimulation of the ICc (Figure 5a). Mice learned to cross sides of a shuttle box after 
hearing acoustic stimuli at a range of pulse rates from 20 to 300Hz to avoid a foot shock. 
Psychometric functions were obtained for acoustic pulse rates and sound levels from -10 
to 70 dB SPL. Subjects crossed with increasing probability for higher sound levels 
(Figure 5b). The slopes of the psychometric functions were estimated by a linear fit of the 
data, calculated to represent the salience of the acoustic stimuli and did not vary across 
injection types (mixed-design ANOVA; n=3/3/2, df=2, p=0.40). However, the 
psychometric slopes were affected by NBN pulse rate (Mixed-design ANOVA, Chronos 
vs. ChR2 vs. saline, n=3/3/2, df=4, p=1.5x10^-3; Figure 5d). 
Murine subjects were then implanted with chronic optic fibers into the previously 
injected ICc. The sound detection task was repeated with photostimulation to the 
midbrain and Chronos and ChR2 animals immediate generalized the task across 
stimulation sources. Increasing laser amplitude resulted in improved crossing probability 
in all subjects (Figure 5c). However, the psychometric detection slopes of Chronos and 
ChR2 injected animals were not significantly different (one-way ANOVA: n=3/3, df=1, 
p=0.73; Figure 5e) and did not vary with pulse rate (one-way ANOVA: n=3/3, df=4, 
p=0.32). The rate of detection was at chance in saline-injected animals, suggesting that 
behavior in virus-infected animals could not be explained by thermal or visual cues 
during photostimulation.  
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In summary, behavioral studies of opsin expressing mice were not consistent with 
predictions that Chronos would be superior to ChR2 in encoding photostimulation in the 
auditory midbrain. Additional experiments by collaborators explored whether this could 
be explained by changes made to the transmitted signals at higher order regions of the 
auditory central nervous system. In the same mice that performed the behavioral task, 
multi-unit recordings were taking from the auditory cortex as animals were subjected to 
acoustic pulse trains or photostimulation of the ICc. Optogenetic activation of auditory 
neurons in the midbrain evoked brief, non-synchronized onset responses (occurring 
<50ms after time of photostimulation), followed by rapid suppression (Supplemental 
Figure A). In comparison, acoustic stimulation evoked significantly more robust 
responses than laser timulation of either ChR2 or Chronos-expressing neurons (one-way 
ANOVAs; NBN vs. ChR2: n=136/64, df=1, p<1x10^-196; NBN vs. Chronos: n=136/72, 





Modern auditory prostheses are a result of decades of bioengineering and have 
improved the lives of deaf patients worldwide. For those who use cochlear implants and 
auditory brainstem implants, software and hardware improvements have dramatically 
changed the quality of the auditory output. However, the basic paradigm for electrically 
stimulating implants has not changed since Dr. William F. House first inserted a simple 
electrical wire into a patient’s cochlea in 1972. The physical limitations of electrical 
implants inspired this thesis to explore new technologies in pursuit of a better hearing 
prosthesis. Optogenetics offers a method of stimulating neurons with light, bypassing the 
intrinsic limitations of electrical systems in hopes of reproducing the fine grained 
frequency resolution of the human auditory nervous system. 
Inspired by the recent discovery of the ultra-fast opsin Chronos, we compared 
optical stimulation with Chronos and conventional ChR2 in the murine ICc. We found 
that Chronos supports a superior non-adapting code with high temporal fidelity at the 
speeds required to encode auditory information in vivo. The fidelity and salience of pulse 
trains encoded by Chronos was superior to those of ChR2 (Figures 2-4). However, these 
advantages were not apparent in behavioral experiments where Chronos and ChR2 
expressing animals were trained to perform an auditory detection task (Figure 5). When 
signals produced by laser stimulation of the ICc were traced to the auditory cortex, 
Chronos and ChR2 encoded neural responses were non-synchronized and rapidly 
suppressed (Supplemental figure A). 
The limitations of this current project are a reflection of time and resource 
constraints. First, the behavioral model consisted of only a detection task. The inability of 
our auditory detection task to discern the differences between Chronos and ChR2 could 
be further probed with a more complicated discrimination experiment. Animals could be 
trained to cross a shuttle box when exposed to a high acoustic pulse rate (e.g. 300 Hz) 
and ignore low pulse rates (e.g. 40 Hz). With photostimulation of the midbrain, Chronos 
and ChR2-expressing animals may show disparate abilities to perform this task. 
Presumably, given our in vivo neurophysiology results, Chronos-expressing mice would 
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be better able to generalize across stimulation modalities. In the event that ChR2 
expressing animals are able to distinguish between the two pulse rates because the rapidly 
adapting onset responses at high pulse rates remain distinct from the more clearly 
encoded pulse train at lower frequencies, the discriminability of increasingly similar 
frequencies can be tested: animals could be serially trained to identify diminishing 
differences in high pulse rates (e.g. 300 Hz vs. 80 Hz, then 300 Hz vs. 120 Hz, etc), such 
that animals expressing Chronos may eventually demonstrate a competitive advantage 
because ChR2 expressing neurons encode high pulse rates with low fidelity.  
However, these hypothetical experiments comparing Chronos and ChR2 in 
photostimulation discrimination tasks may prove unfruitful as we found that cortical 
responses to optogenetic stimulation of the auditory midbrain are poorly encoded and 
quickly suppressed. This is consistent with previous reports of weak cortical responses 
after electrical stimulation of single sites in the ICc, as compared with increased cortical 
activity when multiple isofrequency sites are stimulated simultaneously (53,54). This 
highlights a second limitation of this study in that the optical fiber size we used was 
relatively large compared to the size of the murine inferior colliculus. Stimulation 
through a single large laser beam may have triggered the activity of inhibitory 
interneurons (55,56). The cortex may therefore be more responsive to more complex 
afferent signals characterized by spatiotemporally differentiated patterns of information. 
More compact, denser arrays of optical electrodes would allow better localization of 
neuron stimulation that might then target specific areas of the auditory midbrain to mimic 
more natural patterns of neuron firing. Towards this end, research in material science has 
recently developed thin-film flexible LED arrays that can be miniaturized for such a 
biomedical application (57,58).   
A third limitation to this study is found in the virals vectors we used, which were 
provided in the form of live virus so that we could not easily change the promoter 
sequences driving opsin expression. Chronos was driven by a Synapsin promoter that has 
been found to be active primarily in neurons (59), whereas ChR2 was preceded by a CAG 
promoter that drives high levels of gene expression in many mammalian cell-types 
(60,61). This introduced a confounding factor in our comparisons despite our histological 
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verification that both opsins appeared to be widely expressed in neurons of the ICc. 
Future experiments should explore a variety of promoters to target specific cell 
populations. 
Future experiments 
More sophisticated genetic and bioengineering approaches may make it possible 
to discern how spatially differentiated populations of neurons in the brainstem can be 
activated in a way that more closely mimics patterns of natural auditory information. This 
may be particularly important for central auditory prostheses given that the large drop in 
performance of ABIs as compared with cochlear implants may be attributable to the 
enormous complexity of the brain as compared with peripheral nerve fibers. While 
modern ABIs electrically stimulate vast areas of interconnected neurons and supporting 
cells, optogenetic tools might one day allow stimulation of targeted auditory networks.  
For example, viral constructs with cell-type specific promoters can be used to drive 
expression of opsins in excitatory neurons. One technical hurdle will be that some cell-
specific promoters may not be driven with enough efficiency to allow consistent levels of 
opsin expression.  
Alternatively, through bioengineering, a palette of opsins responsive to non-
overlapping wavelengths of light can used to drive more complex patterns of stimulation. 
Multiple opsins can be introduced simultaneously, either via numerous viral constructs or 
a single construct expressing multiple channelrhodopsins that are stochastically 
expressed,  such as in “Autobow” mice (62). This, combined with smaller and more 
dynamic optical arrays, can greatly improve the complexity of the transmitted code. With 
the use of multichannel micro LED arrays, new strategies for speech processing will need 
to be developed to code incoming sound into complex patterns of optical stimulation. 
These future experiments will simultaneously explore a more nuanced understanding of 
the natural patterns of neuronal firing that transmit the most accurate information to 
higher levels of the brain, as read out by behavioral and neurophysiological experiments. 
After longitudinally studies in animal models, further technical and ethical issues 
regarding the safe and efficient usage of optogenetic technology in humans will need to 
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be explored. Notably, the use of live viruses in humans will be addressed not only in this 
field of research but across many that depend on the viral expression of novel genes as a 
component of therapy (63). To date, AAVs have proven safe for use in the human eye for 
the treatment of Leber’s congenital amaurosis and is poised for application in a number 
of other clinical areas (64). Specific investigation into the species and strains of virus best 
suited for efficient infection and sustained gene expression in the auditory nervous 
system will be necessary, beginning with rigorous rodent and nonhuman primate studies. 
Ultimately, the success of auditory implants over the past four decades serves to 
emphasize that the auditory prosthesis is actually a testament to the remarkable ability of 
the human brain to adapt. It is surprising that the small number of electrodes in modern 
cochlear implants can allow the majority of postlingually deafened patients to perceive 
speech and even some elements of music (29). In patients with ABIs, results have been 
more varied for different surgical candidates but have been particularly successful for 
younger patients, no doubt due to their superior neural plasticity as compared with older 
individuals. A 12 year follow-up of deaf children with ABIs found that 41% developed 
open set speech recognition (65). The improved, optogenetic auditory prosthesis of the 
future need not be perfect, but simply better able to simulate the complex neural circuits 
that govern auditory perception.  
Conclusion 
Optogenetic technology opens new doors to the design of a better auditory 
prosthesis. Here, we have demonstrated that the novel opsin Chronos can encode a wider 
range of temporal stimulation rates with better discriminability compared with standard 
ChR2. Specifically, Chronos-expressing neurons can entrain pulse rates comparable to 
the fast firing speeds of central auditory neurons. However, in our behavioral model of an 
optogenetic midbrain implant, Chronos does not enable better detection of an auditory 
stimulus triggered by laser stimulation. This project underscores the complexity of the 
central auditory neural circuits that prostheses aim to replicate and sets a foundation for 




 Auditory implants have improved the lives of thousands of patients worldwide 
who suffer from hearing loss. Modern devices like cochlear implants and auditory 
brainstem implants use electricity to stimulate neurons of the auditory system to generate 
sensations of sound. Electrical implants are limited in their ability to target small groups 
of neurons because crosstalk between neighboring electrodes blurs the resulting signal. 
Thus, light stimulation has been proposed as light can be more easily focused. To 
sensitize neurons to light, neurons are infected with viruses expressing membrane 
channel proteins that allow ions to move into and depolarize neurons in the presence of 
photons. This technology is called “optogenetics.”  
In this project, we created the first mouse model of an optogenetic auditory 
implant that stimulates auditory neurons of the midbrain. Using this model, we compared 
a new ultra-fast channel protein called Chronos with the well-known but slower protein 
channelrhodopsin 2 (ChR2). We found that Chronos allows auditory neurons to fire much 
faster than those expressing ChR2, at speeds comparable with those of midbrain neurons 
excited by sound. However, we found that this advantage was not apparent when we 
trained animals to perform a behavioral task in response sound. When their auditory 
neurons were stimulated with light, Chronos and ChR2 expressing mice performed the 
task equally well. This project represents an important step towards building the 





Alexopoulou, A. N., Couchman, J. R., & Whiteford, J. R. (2008). The CMV early 
enhancer/chicken beta actin (CAG) promoter can be used to drive transgene expression 
during the differentiation of murine embryonic stem cells into vascular progenitors. BMC 
Cell Biology, 9, 2. http://doi.org/10.1186/1471-2121-9-2 
Asokan, A., Schaffer, D. V., & Jude Samulski, R. (2012). The AAV Vector Toolkit: Poised at the 
Clinical Crossroads. Molecular Therapy, 20(4), 699–708. http://doi.org/10.1038/mt.2011.287 
Baskent, D. (2006). Speech recognition in normal hearing and sensorineuronal hearing loss as a 
function of the number of spectral channels. J Acoust Soc Am, 120(5), 2908–25. 
Beadle, E. A. R., McKinley, D. J., Nikolopoulos, T. P., Brough, J., O’Donoghue, G. M., & 
Archbold, S. M. (2005). Long-term functional outcomes and academic-occupational status in 
implanted children after 10 to 14 years of cochlear implant use. Otology & Neurotology: 
Official Publication of the American Otological Society, American Neurotology Society [and] 
European Academy of Otology and Neurotology, 26(6), 1152–1160. 
Bernstein, J. G., Han, X., Henninger, M. A., Ko, E. Y., Qian, X., Franzesi, G. T., … Boyden, E. 
S. (2008). Prosthetic systems for therapeutic optical activation and silencing of genetically-
targeted neurons. Proceedings - Society of Photo-Optical Instrumentation Engineers, 6854, 
68540H. http://doi.org/10.1117/12.768798 
Bingabr, M., Espinoza-Varas, B., & Loizou, P. C. (2008). Simulating the effect of spread of 
excitation in cochlear implants. Hearing Research, 241(1–2), 73–79. 
http://doi.org/10.1016/j.heares.2008.04.012 
Boëx, C., de Balthasar, C., Kós, M.-I., & Pelizzone, M. (2003). Electrical field interactions in 
different cochlear implant systems. The Journal of the Acoustical Society of America, 114(4 
Pt 1), 2049–2057. 
26 
 
Boyden, E. S., Zhang, F., Bamberg, E., Nagel, G., & Deisseroth, K. (2005). Millisecond-
timescale, genetically targeted optical control of neural activity. Nature Neuroscience, 8(9), 
1263. http://doi.org/10.1038/nn1525 
Brackmann, D. E., Hitselberger, W. E., Nelson, R. A., Moore, J., Waring, M. D., Portillo, F., … 
Telischi, F. F. (1993). Auditory brainstem implant: I. Issues in surgical implantation. 
Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of 
Otolaryngology-Head and Neck Surgery, 108(6), 624–633. 
Cai, D., Cohen, K. B., Luo, T., Lichtman, J. W., & Sanes, J. R. (2013). NEW TOOLS FOR THE 
BRAINBOW TOOLBOX. Nature Methods, 10(6), 540–547. 
http://doi.org/10.1038/nmeth.2450 
Calixto, R., Lenarz, M., Neuheiser, A., Scheper, V., Lenarz, T., & Lim, H. H. (2012). 
Coactivation of different neurons within an isofrequency lamina of the inferior colliculus 
elicits enhanced auditory cortical activation. Journal of Neurophysiology, 108(4), 1199–1210. 
http://doi.org/10.1152/jn.00111.2012 
Cardin, J. A., Carlén, M., Meletis, K., Knoblich, U., Zhang, F., Deisseroth, K., … Moore, C. I. 
(2009). Driving fast-spiking cells induces gamma rhythm and controls sensory responses. 
Nature, 459(7247), 663–667. http://doi.org/10.1038/nature08002 
Christian Goßler, C. B. (2014). GaN-based micro-LED arrays on flexible substrates for optical 
cochlear implants. Journal of Physics D: Applied Physics, 47(20), 205401. 
http://doi.org/10.1088/0022-3727/47/20/205401 
Cochlear Implants. (n.d.). Retrieved January 31, 2016, from 
http://www.nidcd.nih.gov/health/hearing/pages/coch.aspx 
Colletti, L., Shannon, R., & Colletti, V. (2012). Auditory brainstem implants for 
neurofibromatosis type 2. Current Opinion in Otolaryngology & Head and Neck Surgery, 
20(5), 353–357. http://doi.org/10.1097/MOO.0b013e328357613d 
27 
 
Colletti, L., Shannon, R. V., & Colletti, V. (2014). The Development of Auditory Perception in 
Children Following Auditory Brainstem Implantation. Audiology & Neuro-Otology, 19(6), 
386–394. http://doi.org/10.1159/000363684 
Colletti, V., Shannon, R. V., Carner, M., Veronese, S., & Colletti, L. (2010). Complications in 
auditory brainstem implant surgery in adults and children. Otology & Neurotology: Official 
Publication of the American Otological Society, American Neurotology Society [and] 
European Academy of Otology and Neurotology, 31(4), 558–564. 
http://doi.org/10.1097/MAO.0b013e3181db7055 
Darrow, K. N., Slama, M. C. C., Kozin, E. D., Owoc, M., Hancock, K., Kempfle, J., … Lee, D. J. 
(2015). Optogenetic stimulation of the cochlear nucleus using channelrhodopsin-2 evokes 
activity in the central auditory pathways. Brain Research, 1599, 44–56. 
http://doi.org/10.1016/j.brainres.2014.11.044 
Darrow, K. N., Slama, M., Kempfle, J., Boyden, E. S., Polley, D. B., Brown, M. C., & Lee, D. J. 
(2013, February). Optogenetic control of central auditory neurons. Association for Research 
in Otolaryngology MidWinter Meeting; Baltimore. 
Donaldson, G. S., Kreft, H. A., & Litvak, L. (2005). Place-pitch discrimination of single- versus 
dual-electrode stimuli by cochlear implant users (L). The Journal of the Acoustical Society of 
America, 118(2), 623–626. 
Ebinger, K., Otto, S., Arcaroli, J., Staller, S., & Arndt, P. (2000). Multichannel auditory 
brainstem implant: US clinical trial results. The Journal of Laryngology and Otology. 
Supplement, (27), 50–53. 
Eisenberg, L. S. (2015). The contributions of William F. House to the field of implantable 
auditory devices. Hearing Research, 322, 52–56. http://doi.org/10.1016/j.heares.2014.08.003 
Eisen, M. D. (2003). Djourno, Eyries, and the first implanted electrical neural stimulator to 
restore hearing. Otology & Neurotology: Official Publication of the American Otological 
28 
 
Society, American Neurotology Society [and] European Academy of Otology and 
Neurotology, 24(3), 500–506. 
Eshraghi, A. A., Nazarian, R., Telischi, F. F., Rajguru, S. M., Truy, E., & Gupta, C. (2012). The 
cochlear implant: historical aspects and future prospects. Anatomical Record (Hoboken, N.J.: 
2007), 295(11), 1967–1980. http://doi.org/10.1002/ar.22580 
Evans, D. G. (1993). Neurofibromatosis 2. In R. A. Pagon, M. P. Adam, H. H. Ardinger, S. E. 
Wallace, A. Amemiya, L. J. Bean, … K. Stephens (Eds.), GeneReviews(®). Seattle (WA): 
University of Washington, Seattle. Retrieved from 
http://www.ncbi.nlm.nih.gov/books/NBK1201/ 
FDA. (2012, November 29). Recently-Approved Devices - Nucleus 24 Auditory Brainstem 
Implant System - P000015 [WebContent]. Retrieved June 11, 2013, from 
http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandCl
earances/Recently-ApprovedDevices/ucm089750.htm 
Fishman, K. E., Shannon, R. V., & Slattery, W. H. (1997). Speech recognition as a function of the 
number of electrodes used in the SPEAK cochlear implant speech processor. Journal of 
Speech, Language, and Hearing Research: JSLHR, 40(5), 1201–1215. 
Fretz, R. J., & Fravel, R. P. (1985). Design and function: a physical and electrical description of 
the 3M House cochlear implant system. Ear and Hearing, 6(3 Suppl), 14S–19S. 
Friesen, L. M., Shannon, R. V., Baskent, D., & Wang, X. (2001). Speech recognition in noise as a 
function of the number of spectral channels: Comparison of acoustic hearing and cochlear 
implants. The Journal of the Acoustical Society of America, 110(2), 1150–1163. 
http://doi.org/10.1121/1.1381538 
Garnham, C., O’Driscoll, M., Ramsden And, R., & Saeed, S. (2002). Speech understanding in 
noise with a Med-El COMBI 40+ cochlear implant using reduced channel sets. Ear and 
Hearing, 23(6), 540–552. http://doi.org/10.1097/01.AUD.0000042224.42442.A5 
29 
 
Geier, L., Barker, M., Fisher, L., & Opie, J. (1999). The effect of long-term deafness on speech 
recognition in postlingually deafened adult CLARION cochlear implant users. The Annals of 
Otology, Rhinology & Laryngology. Supplement, 177, 80–83. 
Golding, N. L., & Oertel, D. (2012). Synaptic integration in dendrites: exceptional need for speed. 
The Journal of Physiology, 590(Pt 22), 5563–5569. 
http://doi.org/10.1113/jphysiol.2012.229328 
Guo, W., Hight, A. E., Chen, J. X., Klapoetke, N. C., Hancock, K. E., Shinn-Cunningham, B. G., 
… Polley, D. B. (2015). Hearing the light: neural and perceptual encoding of optogenetic 
stimulation in the central auditory pathway. Scientific Reports, 5. 
http://doi.org/10.1038/srep10319 
Han, X., & Boyden, E. S. (2007). Multiple-Color Optical Activation, Silencing, and 
Desynchronization of Neural Activity, with Single-Spike Temporal Resolution. PLoS ONE, 
2(3), e299. http://doi.org/10.1371/journal.pone.0000299 
Hearing Implants - Large View. (n.d.). Retrieved January 31, 2016, from 
http://www.nf2is.org/implants.php 
Hernandez, V. H., Gehrt, A., Reuter, K., Jing, Z., Jeschke, M., Mendoza Schulz, A., … Moser, T. 
(2014). Optogenetic stimulation of the auditory pathway. The Journal of Clinical 
Investigation, 124(3), 1114–1129. http://doi.org/10.1172/JCI69050 
Hight, A. E., Kozin, E. D., Darrow, K., Lehmann, A., Boyden, E., Brown, M. C., & Lee, D. J. 
(2015). Superior temporal resolution of Chronos versus channelrhodopsin-2 in an optogenetic 
model of the auditory brainstem implant. Hearing Research, 322, 235–241. 
http://doi.org/10.1016/j.heares.2015.01.004 
Improving hearing through a cochlear implant. (n.d.). Retrieved from http://www.mrc-
cbu.cam.ac.uk/improving-health-and-wellbeing/cochlear-implant/ 
Kang, R., Nimmons, G. L., Drennan, W., Longnion, J., Ruffin, C., Nie, K., … Rubinstein, J. 
(2009). Development and validation of the University of Washington Clinical Assessment of 
30 
 
Music Perception test. Ear and Hearing, 30(4), 411–418. 
http://doi.org/10.1097/AUD.0b013e3181a61bc0 
Kaplan, A. B., Kozin, E. D., Puram, S. V., Owoc, M. S., Shah, P. V., Hight, A. E., … Lee, D. J. 
(2015). Auditory Brainstem Implant Candidacy in the United States in Children 0-17 Years 
Old. International Journal of Pediatric Otorhinolaryngology, 79(3), 310–315. 
http://doi.org/10.1016/j.ijporl.2014.11.023 
Kay, M. A., Glorioso, J. C., & Naldini, L. (2001). Viral vectors for gene therapy: the art of 
turning infectious agents into vehicles of therapeutics. Nature Medicine, 7(1), 33–40. 
http://doi.org/10.1038/83324 
Klapoetke, N. C., Murata, Y., Kim, S. S., Pulver, S. R., Birdsey-Benson, A., Cho, Y. K., … 
Boyden, E. S. (2014). Independent optical excitation of distinct neural populations. Nature 
Methods, 11(3), 338–346. http://doi.org/10.1038/nmeth.2836 
Kohlberg, G., Spitzer, J. B., Mancuso, D., & Lalwani, A. K. (2014). Does cochlear implantation 
restore music appreciation? The Laryngoscope, 124(3), 587–588. 
http://doi.org/10.1002/lary.24171 
Kuchta, J., Otto, S. R., Shannon, R. V., Hitselberger, W. E., & Brackmann, D. E. (2004). The 
multichannel auditory brainstem implant: how many electrodes make sense? Journal of 
Neurosurgery, 100(1), 16–23. http://doi.org/10.3171/jns.2004.100.1.0016 
Kügler, S., Meyn, L., Holzmüller, H., Gerhardt, E., Isenmann, S., Schulz, J. B., & Bähr, M. 
(2001). Neuron-Specific Expression of Therapeutic Proteins: Evaluation of Different Cellular 
Promoters in Recombinant Adenoviral Vectors. Molecular and Cellular Neuroscience, 17(1), 
78–96. http://doi.org/10.1006/mcne.2000.0929 
Lenarz, T., Moshrefi, M., Matthies, C., Frohne, C., Lesinski-Schiedat, A., Illg, A., … Samii, M. 
(2001). Auditory brainstem implant: part I. Auditory performance and its evolution over time. 
Otology & Neurotology: Official Publication of the American Otological Society, American 
Neurotology Society [and] European Academy of Otology and Neurotology, 22(6), 823–833. 
31 
 
Lim, H. H., Lenarz, T., Anderson, D. J., & Lenarz, M. (2008). The auditory midbrain implant: 
Effects of electrode location. Hearing Research, 242(1–2), 74–85. 
http://doi.org/10.1016/j.heares.2008.02.003 
Li, Y., Ibrahim, L. A., Liu, B., Zhang, L. I., & Tao, H. W. (2013). Linear Transformation of 
Thalamocortical input by Intracortical Excitation. Nature Neuroscience, 16(9). 
http://doi.org/10.1038/nn.3494 
Matthies, C., Thomas, S., Moshrefi, M., Lesinski-Schiedat, A., Frohne, C., Battmer, R. D., … 
Samii, M. (2000). Auditory brainstem implants: current neurosurgical experiences and 
perspective. The Journal of Laryngology and Otology. Supplement, (27), 32–36. 
Middlebrooks, J. C., & Snyder, R. L. (2007). Auditory prosthesis with a penetrating nerve array. 
Journal of the Association for Research in Otolaryngology: JARO, 8(2), 258–279. 
http://doi.org/10.1007/s10162-007-0070-2 
Miller, C. A., Abbas, P. J., Robinson, B. K., Nourski, K. V., Zhang, F., & Jeng, F.-C. (2006). 
Electrical Excitation of the Acoustically Sensitive Auditory Nerve: Single-Fiber Responses to 
Electric Pulse Trains. Journal of the Association for Research in Otolaryngology, 7(3), 195–
210. http://doi.org/10.1007/s10162-006-0036-9 
Miyazaki, J., Takaki, S., Araki, K., Tashiro, F., Tominaga, A., Takatsu, K., & Yamamura, K. 
(1989). Expression vector system based on the chicken beta-actin promoter directs efficient 
production of interleukin-5. Gene, 79(2), 269–277. 
Moser, T. (2015). Optogenetic stimulation of the auditory pathway for research and future 
prosthetics. Current Opinion in Neurobiology, 34, 29–36. 
http://doi.org/10.1016/j.conb.2015.01.004 
Nevison, B., Laszig, R., Sollmann, W.-P., Lenarz, T., Sterkers, O., Ramsden, R., … von 
Wallenberg, E. (2002). Results from a European clinical investigation of the Nucleus 
multichannel auditory brainstem implant. Ear and Hearing, 23(3), 170–183. 
32 
 
O’Donoghue, G. (2013). Cochlear Implants — Science, Serendipity, and Success. New England 
Journal of Medicine, 369(13), 1190–1193. http://doi.org/10.1056/NEJMp1310111 
Otto, S. R., Brackmann, D. E., & Hitselberger, W. (2004). Auditory brainstem implantation in 12- 
to 18-year-olds. Archives of Otolaryngology--Head & Neck Surgery, 130(5), 656–659. 
http://doi.org/10.1001/archotol.130.5.656 
Otto, S. R., Shannon, R. V., Wilkinson, E. P., Hitselberger, W. E., McCreery, D. B., Moore, J. K., 
& Brackmann, D. E. (2008). Audiologic outcomes with the penetrating electrode auditory 
brainstem implant. Otology & Neurotology: Official Publication of the American Otological 
Society, American Neurotology Society [and] European Academy of Otology and 
Neurotology, 29(8), 1147–1154. http://doi.org/10.1097/MAO.0b013e31818becb4 
Peron, S., & Svoboda, K. (2011). From cudgel to scalpel: toward precise neural control with 
optogenetics. Nature Methods, 8(1), 30. http://doi.org/10.1038/nmeth.f.325 
Richter, C.-P., Rajguru, S. M., Matic, A. I., Moreno, E. L., Fishman, A. J., Robinson, A. M., … 
Walsh, J. T. (2011). Spread of cochlear excitation during stimulation with pulsed infrared 
radiation: inferior colliculus measurements. Journal of Neural Engineering, 8(5), 056006. 
http://doi.org/10.1088/1741-2560/8/5/056006 
Richter, C.-P., & Tan, X. (2014). Photons and neurons. Hearing Research, 311, 72–88. 
http://doi.org/10.1016/j.heares.2014.03.008 
Shimano, T., Fyk-Kolodziej, B., Mirza, N., Asako, M., Tomoda, K., Bledsoe, S., … Holt, A. G. 
(2013). Assessment of the AAV-mediated expression of channelrhodopsin-2 and 
halorhodopsin in brainstem neurons mediating auditory signaling. Brain Research, 1511, 
138–152. http://doi.org/10.1016/j.brainres.2012.10.030 
Stickney, G. S., Loizou, P. C., Mishra, L. N., Assmann, P. F., Shannon, R. V., & Opie, J. M. 
(2006). Effects of electrode design and configuration on channel interactions. Hearing 
Research, 211(1–2), 33–45. http://doi.org/10.1016/j.heares.2005.08.008 
33 
 
Straka, M. M., McMahon, M., Markovitz, C. D., & Lim, H. H. (2014). Effects of location and 
timing of co-activated neurons in the auditory midbrain on cortical activity: implications for a 
new central auditory prosthesis. Journal of Neural Engineering, 11(4), 046021. 
http://doi.org/10.1088/1741-2560/11/4/046021 
Verma, R. U., Guex, A. A., Hancock, K. E., Durakovic, N., McKay, C. M., Slama, M. C. C., … 
Lee, D. J. (2014). Auditory responses to electric and infrared neural stimulation of the rat 
cochlear nucleus. Hearing Research, 310, 69–75. http://doi.org/10.1016/j.heares.2014.01.008 
Waltzman, S. B., Cohen, N. L., & Roland, J. T. (1999). A comparison of the growth of open-set 
speech perception between the nucleus 22 and nucleus 24 cochlear implant systems. The 
American Journal of Otology, 20(4), 435–441. 
Wells, J. D., Thomsen, S., Whitaker, P., Jansen, E. D., Kao, C. C., Konrad, P. E., & Mahadevan-
Jansen, A. (2007). Optically mediated nerve stimulation: Identification of injury thresholds. 
Lasers in Surgery and Medicine, 39(6), 513–526. http://doi.org/10.1002/lsm.20522 
Wells, J., Kao, C., Mariappan, K., Albea, J., Jansen, E. D., Konrad, P., & Mahadevan-Jansen, A. 
(2005). Optical stimulation of neural tissue in vivo. Optics Letters, 30(5), 504–506. 
http://doi.org/10.1364/OL.30.000504 











Figure 1. Functional components of auditory implants. (a) Sound from the external 
environment is collected in the microphone and transformed into an electrical code in the 
speech processor. This information is sent from an external transmitter to an internally 
implanted receiver/simulator. (b) In cochlear implants, the stimulator triggers an array of 
electrodes in the cochlea to activate spiral ganglion neurons. (c) In ABIs, the stimulator 
activates an array of electrodes that stimulate neurons of the auditory brainstem. 
Illustrations courtesy of the Medical Research Council – Cognition and Brain Sciences 




Figure 2. Chronos is better able to entrain high frequency pulse rates than ChR2. (a) 
Coronal sections of murine ICc were counterstained with DAPI to reveal robust Chronos-
GFP expression with fainter fluorescence in the commissural axons that pass to the 
contralateral ICc. Optrode recording probes were inserted at the site of the prior injection. 
Scale bar = 0.5mm. (b-c) Rastergrams of ICc recordings in response to trains of laser 
stimulation or NBN. (d) Firing rate adaptation as represented by the ratio of spikes 
evoked by the first and the following stimulus pulses during each train of optogenetic or 





Figure 3. Chronos supports a superior neural code for stimulation rate, as 
quantified by PSTH-based classifier models. (a) Half the recordings (n=10) were used 
to develop templates of responses for a range of frequencies (bottom row) and the 
remaining trials were sorted to the frequency template that they most closely resembled 
(top row). (b-d) Confusion matrices showing correct and incorrect classifications indicate 
that Chronos more accurately classifies high pulse rates than ChR2 or NBN. (e) Mean 
probability of veridical classification decreases with increasing pulse rate for all 
stimulation modalities but Chronos is consistently superior to ChR2 at high frequencies. 





Figure 4. Chronos-mediated neural activity supports a more discriminable code in 
the murine midbrain. (a) Recorded activity from a 2s period surrounding the onset of 
photo or acoustic stimulation (at t=0s) was divided into 0.1s bins. (b) The distribution of 
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spike rates during the spontaneous (t=-1 to 0s) and evoked periods (t=0 to 1s) were 
derived. (c) Z-scores of neural activity from spontaneous and evoked periods were 
calculated and taken absolute values as any changes from the baseline firing rate could 
represent information encoding the incoming stimulation. (d) The difference between 
spontaneous and evoked z-scores was quantified as a d’ metric, a measure of the 




















Figure 5. Behavioral detection of photostimulation is not superior in Chronos-
expressing midbrains. (a) Animals with Chronos, ChR2 or saline injected into their ICc 
were trained to perform a behavioral detection task in response to pulsed noise. Animals 
cross the shuttle box to avoid a foot shock. After successful training, animals were 
implanted with chronic optical fibers at the site of prior injections and the detection task 
was repeated with photostimulation. Correct and false positive crossing probabilities are 
calculated as a function of sound level (b) and laser amplitude (c). The slope of the linear 
fit of psychometric curves is used as a proxy for pulse detection. Psychometric slopes for 
ChR2 and Chronos mice are not significantly different across changing rates of acoustic 




Acute electrophysiology in the auditory cortex 
ChR2+ and Chronos+ mice were anesthetized with ketamine and xylazine, and a 
craniotomy was made over the right auditory cortex. The exposed dura was covered with 
high viscosity silicon oil. Extracellular recordings of multiunit activity were made with 
tungsten electrodes (FHC Co.) positioned in the middle cortical layers. Acoustic stimuli 
were delivered to the contralateral ear via a calibrated in-ear acoustic system. Laser 
stimuli were delivered through the implanted optic fiber in the ipsilateral ICc. Acoustic 
and laser stimulus parameters were identical to the approach used for ICc recordings. 
Since animals at this stage had all completed behavioral training and assessment, the peak 
amplitude used for acoustic and laser stimulation was set to a suprathreshold level 
according to the corresponding behavioral from each mouse (60 dB SPL and 12 dB above 







Supplemental Figure A. PSTHs across all pulse rates show that optical stimulation of 
opsin expressing neurons in the ICc results in brief and quickly suppressed responses at 
the level of the auditory cortex, as compared with more sustained responses when 
stimulated by noise. Figure adapted from Guo et al. 2015 (52).  
